University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green Liquid paraffin (VitA-POS®)

Second line

Status: Green Liquid paraffin (Xailin® night)
Status: Green Liquid paraffin and white soft paraffin 50:50 ointment
Status: Green Liraglutide (Victoza®) injection (GLP1s should all be prescribed by brand name)

THIS IS FOR DIABETES ONLY. Prescribe by brand (Victoza®) to avoid patients inadvertently receiving a different product licensed for obesity.

1.8 mg is non-formulary.

Status: Green Lisinopril tablets
Status: Green Lixisenatide (Lyxumia®)

1st line choice GLP1 for co-prescribing with insulin. RICaD.

Status: Green Lizinna

Umbrella service only

Status: Green Lofepramine suspension

Specialist initiation only

Status: Green Lofepramine tablets

Specialist initiation only

Status: Green Loperamide capsules

Capsules are more cost effective than tablets

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top